Head down tilt 15° in experimental intracerebral hemorrhage: a randomized noninferiority safety trial
European Journal of Neurology2020Vol. 28(2), pp. 525–531
Citations Over Time
Simone Beretta, Alessandro Versace, Bortolo Martini, M Viganò, Susanna Diamanti, Cristiano Pini, G. Paternò, Davide Carone, Jean Mariani, L Monza, Mattéo Riva, G. Padovano, Emanuela Rossi, Giuseppe Citerio, Giovanna Castoldi, Francesco Padelli, Isabella Giachetti, Domenico Aquino, Carlo Giussani, Erik P. Sganzerla, Carlo Ferrarese
Abstract
Application of HDT15° in the hyperacute phase of experimental intracerebral hemorrhage does not worsen early outcome. Further research is needed to implement HDT15° as an emergency collateral therapeutic for acute stroke.
Related Papers
- → Asymmetrical modulation of interleukin-10 release in patients with intracerebral hemorrhage(2003)5 cited
- Intensive blood pressure reduction and early hematoma growth in patients with intracerebral hemorrhage(2010)
- Effects of prophase protection on hematoma enlargement in patients with intracerebral hemorrhage(2010)
- → Effect of Stereotactic Hematoma Aspiration on the NSE Expression after Experimental Intracerebral Hemorrhage(2015)